NCT00726687View on ClinicalTrials.gov

Phase 1b Study of Indibulin in Combination With Capecitabine in Advanced Solid Tumors

PHASE1/PHASE2UnknownINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Advanced Solid Tumors
Interventions
DRUG

indibulin

indibulin, dose escalation, 400-600 mg taken twice every day

DRUG

capecitabine

capecitabine, dose escalation, 875 mg/m2- 1250 mg/m2, taken twice daily for 14 days per 21 day cycle

Trial Locations (3)

Unknown

Indianapolis

Las Vegas

Vancouver

Sponsors
All Listed Sponsors
lead

Alaunos Therapeutics

INDUSTRY